Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$20.94 - $38.01 $19.8 Million - $35.9 Million
-944,563 Reduced 37.2%
1,594,326 $57.1 Million
Q1 2023

May 15, 2023

SELL
$22.92 - $33.76 $36 Million - $53 Million
-1,568,755 Reduced 38.19%
2,538,889 $59.5 Million
Q4 2022

Feb 14, 2023

BUY
$25.44 - $59.78 $6.92 Million - $16.3 Million
272,034 Added 7.09%
4,107,644 $112 Million
Q3 2022

Nov 14, 2022

SELL
$43.66 - $61.0 $28.1 Million - $39.2 Million
-643,410 Reduced 14.36%
3,835,610 $206 Million
Q2 2022

Aug 15, 2022

SELL
$28.82 - $77.35 $38.4 Million - $103 Million
-1,333,214 Reduced 22.94%
4,479,020 $181 Million
Q1 2022

May 16, 2022

BUY
$48.25 - $100.49 $35.6 Million - $74.1 Million
737,845 Added 14.54%
5,812,234 $385 Million
Q4 2021

Feb 14, 2022

BUY
$88.71 - $120.43 $15.9 Million - $21.6 Million
179,453 Added 3.67%
5,074,389 $508 Million
Q3 2021

Nov 15, 2021

BUY
$98.77 - $132.17 $63.1 Million - $84.4 Million
638,573 Added 15.0%
4,894,936 $612 Million
Q2 2021

Aug 16, 2021

BUY
$109.77 - $165.68 $147 Million - $222 Million
1,338,140 Added 45.85%
4,256,363 $529 Million
Q1 2021

May 17, 2021

SELL
$127.04 - $179.1 $78.3 Million - $110 Million
-616,619 Reduced 17.44%
2,918,223 $445 Million
Q4 2020

Feb 16, 2021

SELL
$99.96 - $135.93 $32 Million - $43.5 Million
-320,051 Reduced 8.3%
3,534,842 $456 Million
Q3 2020

Nov 16, 2020

BUY
$80.32 - $111.8 $63.2 Million - $88 Million
786,720 Added 25.64%
3,854,893 $431 Million
Q2 2020

Aug 07, 2020

SELL
$60.49 - $97.5 $44.2 Million - $71.2 Million
-730,277 Reduced 19.23%
3,068,173 $249 Million
Q1 2020

May 13, 2020

SELL
$59.04 - $88.81 $2.14 Million - $3.22 Million
-36,303 Reduced 0.95%
3,798,450 $264 Million
Q4 2019

Feb 13, 2020

BUY
$59.49 - $82.78 $57.1 Million - $79.5 Million
960,325 Added 33.41%
3,834,753 $300 Million
Q3 2019

Nov 13, 2019

BUY
$62.59 - $110.3 $180 Million - $317 Million
2,874,428 New
2,874,428 $183 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.34B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Viking Global Investors LP Portfolio

Follow Viking Global Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Viking Global Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Viking Global Investors LP with notifications on news.